MyFinsight
Home
About
Contact
Back
Income Statement
Raphael Pharmaceutical Inc. (RAPH)
source: myfinsight.com
Download
Download image
Net loss
-$322K
Total financial
expense
-$7K
Operating loss
-$315K
General and
administrative expenses
$174K
Research and development
expenses
$141K
Back